Intravenous tenecteplase shows no benefit in minor ischaemic stroke with intracranial occlusion
1. Return to baseline function was comparable in tenecteplase and standard-of-care groups. 2. More deaths and intracranial hemorrhages were reported ...
Tag: alteplase
Reteplase associated with improved functional outcomes in ischemic stroke patients
1. In a randomized controlled trial of patients who suffered an acute ischemic stroke, the reteplase group reported a greater ...
#VisualAbstract: Intravenous thrombolysis plus endovascular treatment may be more efficacious for acute ischemic stroke
1. The 90-day modified Ranking Scale score was comparable for patients in intravenous thrombolysis plus endovascular treatment versus endovascular treatment ...
Intravenous thrombolysis plus endovascular treatment may be more efficacious for acute ischemic stroke
1. The 90-day modified Ranking Scale score was comparable for patients in intravenous thrombolysis plus endovascular treatment versus endovascular treatment ...
#VisualAbstract: Dual antiplatelet therapy is noninferior to alteplase for patients with minor nondisabling acute ischemic stroke
1. The ARAMIS trial revealed that the rate of favourable neurologic function at 90 days was 93.8% among patients assigned ...
Dual antiplatelet therapy is noninferior to alteplase for patients with minor nondisabling acute ischemic stroke – the ARAMIS trial
1. The ARAMIS trial revealed that the rate of favourable neurologic function at 90 days was 93.8% among patients assigned ...
Intravenous tenecteplase non-inferior to alteplase for patients with acute ischemic strokes
1. A similar proportion of patients in the alteplase group reported a modified Rankin Scale score of 0-1 compared to ...
#VisualAbstract: Addition of argatroban to intravenous alteplase did not improve neurologic outcomes in patients with acute ischemic stroke
Click here to read this study in NEJM
![The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]](https://www.2minutemedicine.com/wp-content/uploads/2013/05/web-cover-classics-with-logo-medicine-BW-small-jpg-350x250.jpg){kind=logo}
The ECASS III trial: Administering alteplase up to 4.5 hours after onset of acute ischemic stroke improves neurological outcomes [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
#VisualAbstract: Thrombectomy alone is inferior to thrombectomy plus alteplase for acute ischemic stroke
1. Fewer patients in the thrombectomy group achieved an MRS score of 0-2 at 90 days compared to thrombectomy with ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
